277 related articles for article (PubMed ID: 18549428)
1. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
[TBL] [Abstract][Full Text] [Related]
2. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
3. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
4. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract][Full Text] [Related]
5. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.
de Cremoux P; Ravery V; Podgorniak MP; Chevillard S; Toublanc M; Thiounn N; Tatoud R; Delmas V; Calvo T; Boccon-Gibod L
Eur Urol; 1997; 32(1):69-74. PubMed ID: 9266235
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
[TBL] [Abstract][Full Text] [Related]
7. Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy.
Hara N; Kasahara T; Kawasaki T; Bilim V; Tomita Y; Obara K; Takahashi K
Br J Cancer; 2001 Aug; 85(4):557-62. PubMed ID: 11506496
[TBL] [Abstract][Full Text] [Related]
8. [Detection of circulating prostatic cells with RT-PCR PSA in prostatic cancer].
de la Taille A; Salomon L; Colombel M; Abbou CC; Chopin D; Groux-Muscatelli B
Prog Urol; 1999 Dec; 9(6):1084-9. PubMed ID: 10658255
[TBL] [Abstract][Full Text] [Related]
9. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.
McIntyre IG; Spreckley K; Clarke RB; Anderson E; Clarke NW; George NJ
Br J Cancer; 2000 Oct; 83(8):992-7. PubMed ID: 10993644
[TBL] [Abstract][Full Text] [Related]
11. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2.
Kawakami M; Okaneya T; Furihata K; Nishizawa O; Katsuyama T
Cancer Res; 1997 Oct; 57(19):4167-70. PubMed ID: 9331068
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the RNA-amplification based methods RT-PCR and NASBA for the detection of circulating tumour cells.
Burchill SA; Perebolte L; Johnston C; Top B; Selby P
Br J Cancer; 2002 Jan; 86(1):102-9. PubMed ID: 11857020
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of complexed prostate-specific antigen for prostate cancer].
Su HW; Li Y; Xu P
Zhonghua Nan Ke Xue; 2003 Sep; 9(6):431-3. PubMed ID: 14574807
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of tandem PSA for the diagnosis and follow-up of prostate cancer].
Okaneya T; Mizusawa H; Taguchi I; Yoneyama T
Hinyokika Kiyo; 1996 Nov; 42(11):861-7. PubMed ID: 8973936
[TBL] [Abstract][Full Text] [Related]
15. [Prostate-specific membrane antigen. A new sensitive molecular indicator in metastasizing prostatic cancer].
Kippersund JT; Haukeland B; Lilleeng BF; Daehlin L; Haukaas S; Høisaeter PA; Ogreid D
Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3612-5. PubMed ID: 8539714
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.
Mikolajczyk SD; Rittenhouse HG
Rinsho Byori; 2004 Mar; 52(3):223-30. PubMed ID: 15137320
[TBL] [Abstract][Full Text] [Related]
17. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
[TBL] [Abstract][Full Text] [Related]
18. [Detection of PSA mRNA in prostate cancer patients' blood].
Ito T; Okubo Y; Tachibana M
Rinsho Byori; 2001 Oct; 49(10):974-7. PubMed ID: 11769474
[TBL] [Abstract][Full Text] [Related]
19. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer.
Allen D; Butt A; Cahill D; Wheeler M; Popert R; Swaminathan R
Ann N Y Acad Sci; 2004 Jun; 1022():76-80. PubMed ID: 15251943
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer detection in BPH patients.
Puppo P; Perachino M; Ricciotti G; Bozzo W
Arch Esp Urol; 1994 Nov; 47(9):867-72. PubMed ID: 7530942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
